COVID-19 Is a Gut Disease Too

When SARS-CoV-2 emerged in 2020, it was classified as a respiratory virus. But within months, it became clear that COVID-19 affects the gastrointestinal tract directly and profoundly. The ACE2 receptor, which the virus uses to enter human cells, is expressed at extremely high levels in the small intestinal epithelium — 100 times higher than in the lungs. Approximately 50 percent of COVID patients shed viral RNA in their stool, and gastrointestinal symptoms (diarrhoea, nausea, abdominal pain, loss of appetite) occur in 20 to 50 percent of cases.

Even patients with mild or primarily respiratory illness show significant changes in their gut microbiome composition that can persist for months after the acute infection resolves.

How COVID Disrupts the Gut Microbiome

Direct Viral Infection of Gut Cells

SARS-CoV-2 directly infects enterocytes, the absorptive cells lining the small intestine. This infection triggers local inflammation, disrupts the intestinal barrier, and alters the environment in which gut bacteria live. Biopsy studies have found viral particles in intestinal tissue weeks to months after respiratory symptoms resolved, suggesting ongoing low-grade gut infection in some individuals.

Specific Microbiome Changes

Multiple studies have documented consistent microbiome alterations in COVID patients:

  • Depleted beneficial bacteria — Faecalibacterium prausnitzii, Eubacterium rectale, and several Bifidobacterium species are consistently reduced during and after COVID infection
  • Enriched opportunistic organisms — Streptococcus, Rothia, Actinomyces, and certain Bacteroides species expand to fill ecological niches vacated by depleted species
  • Reduced short-chain fatty acid production — the depletion of butyrate-producing bacteria means less fuel for colonocytes and weaker barrier function
  • Fungal expansion — Candida species frequently overgrow in the post-COVID gut, particularly in patients who received antibiotics during hospitalisation
A landmark study published in Gut found that the degree of microbiome disruption during acute COVID correlated with the severity of inflammatory markers and predicted which patients would go on to develop long COVID symptoms.

The Long COVID Connection

Long COVID (post-acute sequelae of SARS-CoV-2, or PASC) affects an estimated 10 to 30 percent of all COVID infections. Symptoms include chronic fatigue, brain fog, exercise intolerance, joint pain, breathlessness, and gastrointestinal dysfunction. Emerging evidence suggests that persistent gut dysbiosis is not just a symptom of long COVID but a potential driver of the condition.

Gut-Derived Inflammation

The depleted microbiome and compromised gut barrier seen in long COVID patients allow bacterial components, particularly lipopolysaccharides, to enter the bloodstream. This endotoxemia drives systemic inflammation that can affect virtually every organ system, potentially explaining the multi-system nature of long COVID symptoms.

Viral Persistence in the Gut

Some researchers have found evidence of persistent SARS-CoV-2 or its components in the intestinal tissue of long COVID patients months after initial infection. This viral persistence may maintain ongoing gut inflammation and dysbiosis, creating a self-perpetuating cycle. The gut may function as a viral reservoir that continues to stimulate the immune system long after the virus has been cleared from the respiratory tract.

Neurotransmitter Disruption

The gut produces approximately 90 percent of the body's serotonin and significant quantities of dopamine, GABA, and other neurotransmitters. Microbiome disruption alters the production of these neurotransmitters, potentially contributing to the brain fog, depression, anxiety, and cognitive difficulties reported by long COVID patients.

Rebuilding Gut Health After COVID

Anti-Inflammatory Nutrition

Focus on reducing systemic inflammation through dietary choices:

  • Omega-3 fatty acids from fatty fish three to four times weekly to suppress inflammatory cytokines
  • Polyphenol-rich foods daily (berries, green tea, turmeric, dark chocolate) to support beneficial bacterial growth
  • Extra-virgin olive oil as the primary cooking fat for its oleocanthal content
  • Eliminate or minimize ultra-processed foods, refined sugar, and alcohol during recovery

Microbiome Restoration

  • Aggressive fermented food intake (four to six servings daily) to reintroduce microbial diversity
  • Prebiotic fibres targeting depleted species: inulin, resistant starch, and beta-glucan
  • Targeted probiotics with species shown to be depleted in post-COVID microbiomes, particularly Bifidobacterium and Lactobacillus strains

Gut Barrier Repair

  • L-glutamine (5 to 10 grams daily) to support enterocyte repair and tight junction integrity
  • Zinc carnosine to support mucosal healing
  • Bone broth for glycine and proline, which support intestinal tissue repair
  • Vitamin D optimization (target serum levels above 40 ng/mL), which modulates both gut immunity and barrier function

When to Seek Specialist Help

If gastrointestinal symptoms persist more than three months after acute COVID infection, particularly if combined with fatigue and cognitive symptoms, evaluation by a gastroenterologist familiar with post-COVID presentations is advisable. Comprehensive stool testing can characterise the current state of your microbiome and guide targeted interventions. GutIQ can help you track the relationship between your gut symptoms and other long COVID manifestations, providing objective data to share with your healthcare team.